Christine L N Bryant
3PUBLICATIONS
11CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (3)
Sort by Publication Date:
|Aug 06, 2025
GLY-200, an oral pharmacologic duodenal exclusion drug, resulted in positive effects on glucose, lipids and bodyweight in patients with type 2 diabetes: Results of a randomized, double-blind placebo-controlled trial.Christine L N Bryant, Kevin Colbert, Marcus Hompesch
|May 30, 2025
Development of a targeted oral pharmacologic duodenal exclusion therapy for the treatment of metabolic diseases.Taylor L Carlson, Kevin Colbert, Marcela Vieira
|Jun 28, 2023
First-in-human study of a pharmacological duodenal exclusion therapy shows reduced postprandial glucose and insulin and increased bile acid and gut hormone concentrations.Mark S Fineman, Christine L N Bryant, Kevin Colbert
Pageof 1
Frequent Collaborators
2 joint publications
Mark S Fineman
2 joint publications
Thomas H Jozefiak
1 joint publications
Christopher K Rayner
1 joint publications
Taylor L Carlson
1 joint publications
Marcela Vieira
1 joint publications
Florence V Guerina
1 joint publications
Kirk Habegger
1 joint publications
Pankaj Jay Pasricha
1 joint publications
John Petersen
1 joint publications
Ashish Nimgaonkar
